We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$21.6B
AUM Growth
+$3.73B
Cap. Flow
+$2.14B
Cap. Flow %
9.89%
Top 10 Hldgs %
20.71%
Holding
1,837
New
181
Increased
1,318
Reduced
286
Closed
50

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34M
2
XOM icon
ExxonMobil
XOM
+$33.1M
3
JNJ icon
Johnson & Johnson
JNJ
+$32.7M
4
MMM icon
3M
MMM
+$32.4M
5
MCD icon
McDonald's
MCD
+$32.3M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Financials 12.4%
3 Industrials 11.69%
4 Healthcare 11.57%
5 Consumer Staples 11.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNFP icon
826
Pinnacle Financial Partners Inc
PNFP
$15.5B
$912K ﹤0.01%
14,252
+331
+2% +$20K
PACW
827
DELISTED
PacWest Bancorp
PACW
$909K ﹤0.01%
23,749
+979
+4% +$36.8K
PWR icon
828
Quanta Services
PWR
$93.9B
$907K ﹤0.01%
22,285
+5,113
+30% +$209K
HALO icon
829
Halozyme
HALO
$9.72B
$906K ﹤0.01%
51,093
-4,816
-9% -$83.4K
DAY
830
DELISTED
Dayforce
DAY
$906K ﹤0.01%
13,344
+9,153
+218% +$506K
RARE icon
831
Ultragenyx Pharmaceutical
RARE
$2.65B
$905K ﹤0.01%
21,199
-1,918
-8% -$79.1K
SAGE
832
DELISTED
Sage Therapeutics
SAGE
$898K ﹤0.01%
12,444
-2,754
-18% -$339K
CTLT
833
DELISTED
CATALENT, INC.
CTLT
$896K ﹤0.01%
15,910
+1,472
+10% +$75K
CPRI icon
834
Capri Holdings
CPRI
$1.77B
$895K ﹤0.01%
23,463
-19,278
-45% -$665K
LIVN icon
835
LivaNova
LIVN
$4.3B
$893K ﹤0.01%
11,842
+1,532
+15% +$116K
LFUS icon
836
Littelfuse
LFUS
$10.2B
$890K ﹤0.01%
4,651
+2,698
+138% +$495K
XHR
837
Xenia Hotels & Resorts
XHR
$1.98B
$889K ﹤0.01%
41,146
+1,799
+5% +$38K
VEEV icon
838
Veeva Systems
VEEV
$30.3B
$883K ﹤0.01%
6,275
+159
+3% +$23.4K
FOLD
839
DELISTED
Amicus Therapeutics
FOLD
$875K ﹤0.01%
89,788
-8,282
-8% -$75.8K
CXW icon
840
CoreCivic
CXW
$3.1B
$874K ﹤0.01%
50,259
+2,748
+6% +$43.5K
VRE
841
DELISTED
Veris Residential
VRE
$871K ﹤0.01%
37,645
+2,045
+6% +$44.3K
BIO icon
842
Bio-Rad Laboratories Class A
BIO
$8.42B
$870K ﹤0.01%
2,352
+226
+11% +$79.7K
MTZ icon
843
MasTec
MTZ
$26.7B
$869K ﹤0.01%
13,540
+1,888
+16% +$124K
IVR icon
844
Invesco Mortgage Capital
IVR
$776M
$868K ﹤0.01%
5,216
+230
+5% +$36.9K
CZR icon
845
Caesars Entertainment
CZR
$6.1B
$863K ﹤0.01%
14,468
+2,050
+17% +$101K
GNRC icon
846
Generac Holdings
GNRC
$11.9B
$863K ﹤0.01%
8,575
+1,341
+19% +$125K
PPLI
847
People Inc
PPLI
$3.1B
$862K ﹤0.01%
19,366
+336
+2% +$13.5K
PEX icon
848
ProShares Global Listed Private Equity ETF
PEX
$11.2M
$856K ﹤0.01%
24,749
+155
+0.6% +$5.38K
ELME
849
Elme Communities
ELME
$132M
$855K ﹤0.01%
29,289
+1,408
+5% +$41.9K
CGNX icon
850
Cognex
CGNX
$10.3B
$854K ﹤0.01%
15,246
+1,693
+12% +$87.6K

Similar funds

ProShare Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, ProShare Advisors held 1,837 positions worth $21.6B, up 21% from $17.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

ProShare Advisors deployed $2.14B of net new capital in Q4 2019, opening 181 new positions and adding to 1,318 existing holdings. Its largest new stake was Pennant Group: 484,308 shares worth $16M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was W.R. Berkley, an estimated $12.8M trimmed.

  • ProShare Advisors's largest Q4 2019 buy was Pennant Group: 484,308 shares worth $16M.
  • ProShare Advisors added most to Alphabet (Google) Class A in Q4 2019, an estimated $34M increase.
  • ProShare Advisors's biggest Q4 2019 reduction was W.R. Berkley, cutting an estimated $12.8M.
  • ProShare Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $70M.
  • ProShare Advisors's ten largest holdings make up 21% of its $21.6B portfolio in Q4 2019.
  • ProShare Advisors opened 181 new positions and closed 50 in Q4 2019.
  • ProShare Advisors's portfolio value rose 21% quarter-over-quarter to $21.6B.

Based on ProShare Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.